KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Prepaid Assets (2016 - 2025)

Thermo Fisher Scientific's Prepaid Assets history spans 17 years, with the latest figure at $2.6 billion for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 32.99% year-over-year to $2.6 billion, compared with a TTM value of $2.6 billion through Dec 2025, up 32.99%, and an annual FY2025 reading of $2.6 billion, up 32.99% over the prior year.
  • Prepaid Assets for Q4 2025 was $2.6 billion at Thermo Fisher Scientific, up from $2.5 billion in the prior quarter.
  • The five-year high for Prepaid Assets was $2.6 billion in Q4 2025, with the low at $1.3 billion in Q3 2021.
  • Average Prepaid Assets over 5 years is $1.9 billion, with a median of $1.7 billion recorded in 2022.
  • Year-over-year, Prepaid Assets soared 45.21% in 2021 and then decreased 2.13% in 2023.
  • Tracing TMO's Prepaid Assets over 5 years: stood at $1.6 billion in 2021, then rose by 0.24% to $1.6 billion in 2022, then grew by 6.87% to $1.8 billion in 2023, then rose by 11.78% to $2.0 billion in 2024, then soared by 32.99% to $2.6 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Prepaid Assets are $2.6 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.6 billion (Q2 2025).